MEDICARE Schedules 18 May 2026 AGM; Board Seeks 20% Issuance and 10% Buy-back Mandates

Bulletin Express
04/16

Tian An Medicare Limited will convene its Annual General Meeting at 11:00 a.m. on Monday, 18 May 2026, at Plaza 1-2, Basement 3, Novotel Century Hong Kong, 238 Jaffe Road, Wanchai, Hong Kong.

Key proposals:

1. Financial Statements • Shareholders will vote on adopting the audited financial statements and the directors’ and auditor’s reports for the year ended 31 December 2025.

2. Board Composition and Remuneration • Re-election of four directors: Mr. Lee Seng Hui, Mr. Guo Meibao, Mr. Mark Wong Tai Chun and Mr. Zhou Haiying. • Authorisation for the board to determine directors’ remuneration.

3. Auditor Re-appointment • Deloitte Touche Tohmatsu is nominated for re-appointment as external auditor, with remuneration to be set by the board.

4. General Mandates • Share issuance mandate: Authority for the board to allot and issue new shares or convertible securities up to 20% of the company’s issued share capital as at the AGM date. • Share buy-back mandate: Authority to repurchase shares on the Hong Kong Stock Exchange or other recognised exchanges up to 10% of issued share capital. • Extension mandate: Conditional approval to extend the 20% issuance limit by the number of shares actually repurchased under the 10% buy-back mandate.

Logistics and Voting Arrangements:

• The share register will be closed from 13 May 2026 to 18 May 2026 (both days inclusive); only shareholders on record by 4:30 p.m. on 12 May 2026 are entitled to attend and vote. • All resolutions will be decided by poll, with results disclosed on the websites of the Hong Kong Stock Exchange and the company. • Shareholders may appoint proxies and must lodge proxy forms at Tricor Investor Services Limited or submit electronically no later than 48 hours before the meeting.

Board Composition (current): – Executive Directors: Mr. Kong Muk Yin, Mr. Guo Meibao – Non-Executive Directors: Mr. Lee Seng Hui (Chairman), Mr. Mark Wong Tai Chun, Mr. Zhou Haiying, Mr. Gao Zhaoyuan, Ms. Zhang Yuanyuan – Independent Non-Executive Directors: Dr. Xia Xiaoning, Dr. Wong Wing Kuen, Albert, Ms. Yang Lai Sum, Lisa, Mr. Cao Dan

No immediate plans to issue new securities or repurchase shares have been disclosed; the mandates are sought to maintain board flexibility within the prescribed limits.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10